Continuing Education and Professional Development

The University of Tennessee Medical Center Cancer Institute and the University of Tennessee Graduate School of Medicine Present:

12th Annual Big 4 Cancer Conference: Surgical Innovations, Oncology Advances, Radiation Options, and Pharmacy Updates

September 20-21, 2024

New Location: Dollywood's HeartSong Lodge & Resort
Pigeon Forge, Tennessee

All registration questions should be referred to the UT Conference Center at (865) 974-0280 or Conferences@utk.edu

Course Overview

The Big 4 Cancer Conference for 2024 aims to address four key practice-based challenges in cancer care. Firstly, the conference will tackle gaps in the surgical management of solid organ cancer, aiming to streamline multidisciplinary care and ensure timely treatment. Secondly, it will focus on current systemic therapies for hematologic malignancies, shedding light on recent advancements and the importance of early referrals to cellular therapy teams. The third topic will delve into managing the side effects of systemic therapy, aiming to standardize practices and improve the quality of life for patients. Lastly, the conference will explore the role of radiation oncology, emphasizing standard protocols while discussing exceptions and creative approaches in cancer treatment. These topics aim to equip learners with a better understanding of best practices, current technologies, and resources for optimal cancer care in the region.

Course Objectives

After this program, the participants should be able to:

• Discuss the recommendations, management, and recognition of side effects of immunotherapy for multiple cancer diagnoses.
• Review new technologies implemented for the management of solid organ malignancies.
• Summarize new updates from current and ongoing clinical trials.
• Discuss the role of palliative care and hospice for cancer and treatment-induced symptoms.
• Review the new advances in cellular therapy and the current treatment options
• Discuss multidisciplinary therapies for metastatic solid organ cancers.

Registration Fees

The registration fee covers all sessions, online access to conference materials, continuing education credit, breakfast and breaks on Friday and Saturday, lunch on Friday, and self-parking at the resort.

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Tennessee College of Medicine and the University of Tennessee Medical Center Cancer Institute.  The University of Tennessee College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Education Credits

The University of Tennessee College of Medicine designates this live activity for a maximum of 11 AMA PRA Category 1 Credits.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants and Nurse Practitioners may use these credit hours toward certification renewal.  This credit is acceptable by the American Academy of Physician Assistants and the American Academy of Nurse Practitioners.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

• 11 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program
• 11 MOC points in the American Board of Surgery (ABS) Self-Assessment requirements of the Maintenance of Certification (MOC) program.

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM or ABS MOC credit.

The University of Tennessee Medical Center is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

 The credit request is pending.    

Disclosures

Individuals involved with planning, reviewing, and presenting content for this activity must disclose all financial relationships within the past 24 months with ineligible companies, regardless of the amount. The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company. Individuals must disclose regardless of their view of the relevance of the relationship to the education.

The University of Tennessee Graduate School of Medicine, Office of Continuing Education and Professional Development (CEPD) staff and Activity Director will take appropriate steps to identify and mitigate relationships before the individuals assume their roles.  Currently, the CEPD staff, Activity Director, and Planning Committee wish to disclose they have no financial relationships with ineligible companies.